Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

91.28 +2.05 (+2.30%)
Streaming Delayed Price Updated: 12:36 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - div... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
2 Profitable Stocks to Consider Right Now and 1 We Question
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
Which S&P500 stocks have an unusual volume on Tuesday? ↗
Via Chartmill
Gapping S&P500 stocks in Tuesday's session ↗
Via Chartmill
News headline image
3 Healthcare Stocks That Fall Short
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking... 
Via StockStory
News headline image
3 Reasons to Sell ZBH and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. Th... 
Via StockStory
Topics Stocks
News headline image
Q1 Earnings Highs And Lows: STERIS (NYSE:STE) Vs The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
Topics Artificial Intelligence Economy
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Why Zimmer Biomet (ZBH) Stock Is Up Today
What Happened? Shares of medical device company Zimmer Biomet (NYSE:ZBH) jumped 4.9% in the afternoon session after the company announced it increased its sh... 
Via StockStory
Topics Economy
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
3 Out-of-Favor Stocks We Approach with Caution
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Zimmer Biomet’s Q1 Earnings Call
Zimmer Biomet’s first quarter of 2026 results exceeded Wall Street’s expectations for both revenue and non-GAAP earnings, but the market responded negatively... 
Via StockStory
Topics Earnings
News headline image
These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results ↗
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported strong Q1 earnings, beating estimates and raising guidance. Analysts maintain mixed views on stock. 
Via Benzinga
News headline image
ZBH Q1 Deep Dive: Sales Force Changes, Tech Investments, and Margin Expansion Shape Outlook
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 9.3% year on year to $2... 
Via StockStory
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Zimmer Biomet (ZBH) Q1 2026 Earnings Transcript ↗
Zimmer Biomet (ZBH) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Zimmer Biomet’s (NYSE:ZBH) Q1 CY2026 Sales Beat Estimates
Medical device company Zimmer Biomet (NYSE:ZBH) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 9.3% year on year to $2.09 b... 
Via StockStory
Topics Earnings
News headline image
What To Expect From Zimmer Biomet’s (ZBH) Q1 Earnings
Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Zimm... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 S&P 500 Stock to Own for Decades and 2 We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
Topics Bonds
News headline image
Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript ↗
Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript 
Via The Motley Fool
News headline image
QSM Asset Management Loads Up 611,000 Mobileye Shares ↗
Mobileye develops advanced driver assistance and autonomous driving technologies for global automotive manufacturers and suppliers. 
Via The Motley Fool
Topics Economy Regulatory Compliance Supply Chain
News headline image
A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound? ↗
Robert Half Inc. provides staffing and risk consulting solutions globally to employers across diverse industries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup ↗
ManpowerGroup provides staffing and HR solutions worldwide, serving clients in 75 countries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
CANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting... 
Via MarketMinute
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.